Galmed Pharmaceuticals (GLMD) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2020)
Galmed Pharmaceuticals (GLMD) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
49.07% |
| Dec 31, 2019 |
92.06% |
| Sep 30, 2019 |
453.48% |
| Mar 31, 2019 |
20.53% |
| Dec 31, 2018 |
-29.98% |
| Sep 30, 2018 |
-82.96% |
| Jun 30, 2018 |
-22.71% |
| Mar 31, 2018 |
-34.75% |
| Dec 31, 2017 |
-31.22% |
| Sep 30, 2017 |
-30.26% |
| Jun 30, 2017 |
-43.04% |
| Mar 31, 2017 |
-27.25% |
| Dec 31, 2016 |
46.95% |
| Sep 30, 2016 |
38.69% |
| Jun 30, 2016 |
83.04% |
| Mar 31, 2016 |
65.89% |
| Dec 30, 2015 |
62.03% |
| Sep 30, 2015 |
-18.08% |
| Jun 30, 2015 |
33.07% |
| Mar 31, 2015 |
-93.86% |
